Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival.
Kumar
A M
AM
Department of Transplantation, MCP Hahnemann University, Philadelphia, Pennsylvania 19102, USA.
Fa
K
K
Vankawala
R
R
Vora
M
M
Kode
R K
RK
Pankewycz
O G
OG
Lattavi
M R
MR
Fyfe
B
B
Damask
A M
AM
Ferry
E
E
Stabler
S
S
Tomeny
M B
MB
Phillips
K
K
Lingaraju
R
R
Kumar
M S
MS
D001741:Black or African American; D000368:Aged; D065095:Calcineurin Inhibitors; D003710:Demography; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D012189:Retrospective Studies; D013997:Time Factors; D014019:Tissue Donors / Q000706:statistics & numerical data; D014481:United States
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D009173:Mycophenolic Acid; D011241:Prednisone